A Role for a TIMP-3-Sensitive, Zn2+-Dependent Metalloprotease in Mammalian Gamete Membrane Fusion  by Correa, Liane M. et al.
A Role for a TIMP-3-Sensitive, Zn21-Dependent
M
M
a
m
T
Developmental Biology 225, 124–134 (2000)
doi:10.1006/dbio.2000.9825, available online at http://www.idealibrary.com onetalloprotease in Mammalian Gamete
embrane Fusion
Liane M. Correa,*,1 Chunghee Cho,* Diana G. Myles,*
nd Paul Primakoff†
*Section of Molecular and Cellular Biology, Division of Biological Sciences, and †Department
of Cell Biology and Human Anatomy, School of Medicine, University of California at Davis,
Davis, California 95616
During fertilization, sperm and egg plasma membranes adhere and then fuse by a mechanism that is not well understood.
Zinc metalloproteases are necessary for some intercellular fusion events, for instance, cell–cell fusion in yeast. In this study
we tested the effects of class-specific and family-specific protease inhibitors on mouse gamete fusion. Capacitated,
acrosome-reacted sperm and zona-free eggs were used in assays designed to define the effects of inhibitors on sperm–egg
plasma membrane binding or fusion. Inhibitors of the aspartic, cysteine, and serine protease classes had no effect on
sperm–egg binding or fusion. Both a synthetic metalloprotease substrate (succinyl-Ala-Ala-Phe-amidomethylcoumarin) and
the zinc chelator 1,10-phenanthroline inhibited sperm–egg fusion but did not decrease sperm–egg binding. The fusion-
inhibition effect of phenanthroline was reversible and activity of the inhibitable zinc metalloprotease was shown to be
required during a short time window, the first 15 min after insemination. Tissue inhibitor of metalloprotease-3 and Ro
31-9790, specific inhibitors of zinc metalloproteases in the matrixin and adamalysin families, also inhibited sperm–egg
fusion but not sperm–egg binding. These data indicate a role in gamete fusion for one or more zinc metalloproteases of the
matrixin and/or adamalysin families that act after plasma membrane binding and before sperm–egg membrane
fusion. © 2000 Academic Press
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signaling (Lewis, 1998; Schroeter et al., 1998). One of theRecent research has revealed that protease action regu-
lates the function of key plasma membrane proteins during
development (Hooper et al., 1997). For instance, it is re-
quired for mouse fetal development that transforming
growth factor b (TGF-b) be proteolytically cleaved from its
embrane anchor and released as an active, soluble form.
he zinc metalloprotease tumor necrosis factor a convert-
ing enzyme, TACE (ADAM 17), catalyzes TGF-a cleavage
(Peschon et al., 1998). Another example is Notch, a cell
surface signaling receptor. Notch signaling regulates cell-
fate determination in multiple aspects of vertebrate and
invertebrate development. Proteolytic cleavage is necessary
for activation of Notch. Notch probably undergoes three
1 Present address: Department of Environmental Toxicology,
University of California, Davis, CA 95616.124cleavages that activates Notch may be performed by the
zinc metalloprotease kuzbanian (ADAM 10) (Pan and Ru-
bin, 1997; Lewis, 1998). Alternatively, kuzbanian may pro-
cess to an active form the transmembrane protein Delta,
the ligand of Notch (Qi et al., 1999).
The matrix metalloproteases (MMPs) also degrade and
modify the extracellular matrix during reproduction and
development (Brenner et al., 1989; Matrisian, 1992; McIn-
tush and Smith, 1998). A family of proteins called tissue
inhibitors of metalloproteases (TIMPs) is important for the
regulation of MMP activity and is thought to be coordi-
nately regulated and expressed with various MMPs (Matri-
sian, 1992; Apte et al., 1995). One example of this coordi-
nated expression occurs during the implantation of
mammalian embryos. Gelatinase B (MMP-9) is primarily
responsible for invasion of embryonic trophoblast cells into
0012-1606/00 $35.00
Copyright © 2000 by Academic Press
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the maternal endometrium, while the level of TIMP-3
produced during implantation is thought to control the
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125Metalloprotease in Sperm–Egg Fusiondegree of trophoblast invasion (Graham and Lala, 1991;
Librach et al., 1991; Leco et al., 1996).
Our lab’s interest in development is to understand the
echanism of gamete fusion in mammals. Results from
east fusion studies suggest that cellular fusion events,
otentially related to mammalian gamete fusion, involve
inc metalloproteases. Mutational analysis has demon-
trated that cell–cell fusion in yeast requires the zinc
etalloprotease Axl1p (Elia and Marsh, 1998), an ortholog
f the mammalian zinc metalloprotease IDE (insulin-
egrading enzyme) (Fujita et al., 1994; Adames et al., 1995).
Metalloproteases have previously been reported to have
important roles at two stages during fertilization. Using a
heterologous system (human sperm fusing with zona-free
hamster eggs), Meizel and colleagues used inhibitors to
study an “early” metalloprotease activity. In their studies,
gamete fusion was inhibited only if metalloprotease inhibi-
tors were present during induction of the acrosome reac-
tion. Thus the proposed early metalloprotease is posited to
act on human sperm during the acrosome reaction. This
protease is probably in the acrosomal contents and is
presumed to act on the human sperm surface, thereby
affecting the sperm’s ultimate ability to fuse with zona-free
hamster eggs. In these studies, a 50–60% decrease in the
number of sperm that fused per egg was obtained by
inhibiting the early metalloprotease (Diaz-Perez et al.,
1988; Diaz-Perez and Meizel, 1992). Lennarz and colleagues
studied a “late” sperm metalloprotease activity that acts
after sea urchin sperm have acrosome reacted and bound to
the egg plasma membrane. Inhibiting the late metallopro-
tease resulted in a virtually complete block (.95%) to
gamete fusion (Roe et al., 1988).
Our lab and others have worked to establish the identity
of gamete surface proteins that may function in mamma-
lian sperm–egg plasma membrane binding. These include
the sperm surface proteins fertilin and cyritestin and the
egg integrin a6b1 (Primakoff et al., 1987; Myles et al., 1994;
Almeida et al., 1995; Evans et al., 1995, 1997, 1998; Linder
and Heinlein, 1997; Yuan et al., 1997; Chen et al., 1998;
Cho et al., 1998; Chen and Sampson, 1999). Adhesion
etween sperm and egg plasma membranes may be
chieved by interaction of these molecules (and others) and
his interaction might lead to or regulate subsequent steps
hat result in fusion. In this study we asked if, after mouse
perm–egg binding has occurred, there is another step
nvolving zinc metalloprotease action that must occur
efore membrane fusion.
MATERIALS AND METHODS
Materials and media. Chemicals were purchased from Sigma
unless otherwise indicated. The protease inhibitors used were acti-
nonin, captopril, a2-macroglobulin, 1,10-phenanthroline, phosphor-
midon, and Ro 31-9790 (generously provided by Roche Discovery,Copyright © 2000 by Academic Press. All rightnd recombinant human TIMP-3 proteins were a generous gift from
r. Gillian Murphy (University of East Anglia, Norwich, UK). Syn-
hetic peptides used were N-succinyl-alanine-alanine-alanine-7-
mido-4-methylcoumarin (succ-Ala-Ala-Ala-AMC) and N-succinyl-
lanine-alanine-phenylalanine-7-amido-4-methylcoumarin (succ-Ala-
la-Phe-AMC, a metalloprotease substrate). 4,7-Phenanthroline was
urchased from Aldrich Chemical Co.
Media used were M2 and M16 (Hogan et al., 1994), containing
.3% BSA, and Whittingham’s (Whittingham, 1971) containing 3%
SA. Media used for in vitro fertilization (IVF) assays were equili-
rated under mineral oil overnight at 37°C/5% CO2 in air. All
manipulations of gametes were carried out in equilibrated media
under mineral oil, and incubations were at 37°C/5% CO2, unless
indicated otherwise.
Preparation of gametes. Female (6–8 weeks) and male (10–12
weeks) ICR mice were purchased from Charles River Laboratories
(Wilmington, MA). Female mice were superovulated as described
previously (Yuan et al., 1997). Oviducts were excised from super-
vulated females, and eggs were released into equilibrated M16
edium without mineral oil. Egg–cumulus complexes were trans-
erred into 500-ml drops of M16, and cumulus cells were removed
by treatment with hyaluronidase (300 mg/ml) for 3–5 min. Zona-
ntact eggs were washed in 1 500-ml drop and 4 100-ml drops of M16
and then transferred to a fresh 100-ml drop of M16 to which
hymotrypsin (10 mg/ml) was added. Zonae pellucidae were re-
oved by passing eggs through a narrow-bore Pasteur pipette.
ona-free eggs were quickly transferred into a 100-ml drop of M16
and washed through 4 more drops, then incubated in M16 at
37°C/5% CO2 in air for 3–4 h during the sperm capacitation period.
During this incubation and about 1 h before insemination, eggs
were preloaded with 49,6-diamidino-2-phenylindole (DAPI) dihy-
drochloride (Polysciences, Inc., Warrington, PA), 10 mg/ml, for
2–14 min and then washed through 4 100-ml drops of M16. The
API-stained eggs were returned to M16 until use in IVF assays.
Sperm were obtained by removing the cauda epididymis and vas
eferens from mature males and cutting the tissues into a few
ieces with surgical scissors in Whittingham’s medium, 3% BSA.
his mixture was incubated 15 min to allow sperm to swim out.
issue pieces were removed, then sperm were diluted to approxi-
ately 5 3 105/ml and allowed to capacitate and acrosome react in
Whittingham’s medium, 3% BSA (37°C/5% CO2) for $3 h. In some
assays, undiluted sperm or ;5 3 106 sperm/ml were treated with
inhibitor and then diluted further immediately before insemina-
tion.
In vitro fertilization assays. A variety of compounds were
tested in IVF experiments to screen for an inhibitory effect on
sperm–egg fusion. The following solvents with and without inhib-
itor were added to the insemination drops (maximum final concen-
tration): 0.5% DMSO 6 actinonin (20 mM); M2 6 captopril (100
mM); 0.02 M Tris–glycine, pH 8.0, 6 a2-macroglobulin (1000 units
of activity); 1% DMSO 6 E64 (15 mM); 1% DMSO 6 Pefabloc SC
(1 mM); 1% DMSO 6 pepstatin (1.46 mM); 1–2% DMSO 6 4,7- or
,10-phenanthroline (1 mM); M2 6 phosphoramidon (250 mM); 1%
DMSO 6 succ-Ala-Ala-Ala-AMC or succ-Ala-Ala-Phe-AMC (3
mM); and 1% DMSO 6 Ro 31-9790 (200 mM). The above solvents
(e.g., 1–2% DMSO) were found not to affect the gamete fusion
assay. Test inhibitors or solvent controls were added to diluted
sperm at the end of the capacitation and acrosome reaction period.
Approximately 10 min after the addition of solvents 6 samples,s of reproduction in any form reserved.
zona-free eggs were added to the test and control sperm drops and
incubated for 40 min.
In experiments testing the effects of 1,10-phenanthroline after it
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126 Correa et al.was “washed out” of IVF medium, zona-free eggs were treated with
1 mM 1,10-phenanthroline during the last 30 min of sperm
capacitation. The eggs were then washed through 4 100-ml drops of
M16 and added to diluted, capacitated sperm for fertilization (Fig.
1c). Alternatively, capacitated sperm (;2 3 107 or 5 3 106/ml) were
ncubated with 1 mM 1,10-phenanthroline for 30 min and then
iluted 100-fold in fresh medium. Zona-free eggs were added to
hese washed sperm for fertilization (Fig. 1d). In other experiments,
apacitated sperm (;5 3 105/ml) were co-incubated with zona-free
ggs for 15 min and then 1 mM 1,10-phenanthroline was added to
he insemination drop for the final 25 min of the incubation period
Fig. 1e).
In experiments testing inhibitory activities of purified TIMPs,
IMPs at various concentrations up to 1.2 mM were added to the
test inseminations. Equivalent amounts of the buffer and salt
present in the TIMP sample, but no TIMP, were added to the
control inseminations.
In all IVF experiments, inseminated eggs were washed in 2
100-ml drops of M16 (the first contained ;0.5% paraformaldehyde)
nd transferred to microscope slides prepared with an elevated
overslip. Sperm binding and sperm–egg fusion were scored by
ight microscopy using a Zeiss Axiophot microscope, with a 103 or
03 objective lens. Binding was scored by counting sperm heads
ound to eggs and then calculating the mean number of bound
perm per egg. Fusion was scored by counting sperm heads that
ere fluorescently labeled within the egg cytoplasm, due to trans-
er of DAPI stain from the DAPI-preloaded eggs. Two measures of
usion were determined in all assays: fertilization rate (FR, percent-
ge of eggs fused with at least one sperm) and fertilization index (FI,
ean number of fused sperm per egg). Data were compared using
he Student t test. The IC50 for a protease inhibitor is defined as the
inhibitor concentration that gives half of the maximal inhibition
obtainable with that compound.
RESULTS
Metalloprotease Inhibitors Block Sperm–Egg
Fusion
In order to determine if one or more proteases play a role
in the process of mouse gamete fusion, we tested class-
specific protease inhibitors and a synthetic protease sub-
strate using in vitro adhesion and fusion assays. We have
reviously found that when mouse sperm are capacitated
or $3 h with the protocol used here, spontaneous acrosome
eaction reaches a maximal level, ;60% (Cho et al., 1998;
npublished results). The current experiments were de-
igned so that the capacitation period was $3 h to ensure
hat spontaneous acrosome reaction had reached a maximal
evel before a protease inhibitor was added (the basic
rotocol is shown in Figs. 1a and 1b). The inhibitors tested
ere chosen based on their ability to inhibit virtually all
embers of one specific protease class and have often been
sed to determine the mechanistic class of a newly identi-
ed protease (Beynon and Bond, 1986). Results from these
xperiments are summarized in Table 1. Pepstatin, E64, and
efabloc SC are inhibitors of the aspartic, cysteine, andCopyright © 2000 by Academic Press. All righterine protease classes, respectively. These three inhibitors
ere tested at concentrations inhibitory in other systems
Beynon and Bond, 1986) and had no inhibitory effect on
perm–egg binding or fusion, although they did have an
ffect on sperm viability. Incubation of pepstatin and E64
ith sperm and eggs caused about 50% of the sperm to die
ompared to control assays, yet the remaining sperm were
iable and had normal motility. Despite the effects on
perm viability, enough sperm survived during the incuba-
ion period to bind to and fuse with eggs at levels equivalent
o controls (Table 1). Similarly, we observed that after ;35
in of the sperm–egg incubation with Pefabloc SC, virtu-
lly all sperm had stopped moving. However, in the pres-
FIG. 1. Phenanthroline, a zinc chelator, inhibits fusion only when
present during initial sperm–egg plasma membrane contact. In
these assays, 1 mM 1,10-phenanthroline was used. The basic
protocol is shown in (a): zona-free eggs were incubated in
M1610.3% BSA, while sperm were allowed to capacitate and
acrosome react for $3 h. After capacitation and acrosome reaction,
gametes were co-incubated for 40 min. In (b), 1,10-phenanthroline
was present throughout the 40-min insemination period. In wash-
out experiments, 1,10-phenanthroline was added either to eggs (c)
or to sperm (d), during the last 30 min of sperm capacitation, then
washed out as described under Materials and Methods. In (e),
sperm–egg incubation was initiated for 15 min, then 1,10-
phenanthroline was added to the insemination drop for the remain-
ing 25 min of fertilization. FR is expressed as percentage of control
(no phenanthroline) value. The total number of eggs tested was (a)
115, (b) 50, (c) 30, (d) 43, and (e) 28.s of reproduction in any form reserved.
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127Metalloprotease in Sperm–Egg Fusionence of Pefabloc SC, sperm were bound to and fused with
zona-free eggs at levels either higher than (No. sperm
bound) or equal to (% eggs fused) the control levels
(Table 1).
Inhibitors of the metalloprotease class were found to
strongly inhibit sperm–egg fusion. The tripeptide substrate
succ-Ala-Ala-Phe-AMC (Roe et al., 1988) at relatively high
concentration will inhibit metalloproteases by competing
with endogenous substrates for protease binding (discussed
by Beynon and Bond, 1986). We found that this peptide gave
somewhat variable but substantial inhibition of sperm–egg
fusion, while the control tripeptide succ-Ala-Ala-Ala-AMC,
which is not a metalloprotease substrate, had little effect on
fusion (Table 2). The variation observed was well within
that observed in normal fusion assays. Neither of the two
peptides tested decreased the number of sperm bound per
egg. We also tested the zinc metalloprotease inhibitor
1,10-phenanthroline, a zinc chelator, and found that gamete
fusion was inhibited (Table 1), while binding was either
unaffected or slightly increased (see below). Incubation of
sperm with 1,10-phenanthroline (up to 5 mM) had no effect
on sperm motility or on the ability of sperm nuclei to be
stained by DAPI (data not shown). Based on these findings,
it appears that aspartic, cysteine, and serine proteases are
not involved in gamete fusion, although they may play a
role related to sperm viability. On the other hand, metallo-
proteases may be involved in the fusion process, in one or
more steps after sperm bind to the egg plasma membrane.
A dose–response curve was determined for inhibition of
sperm–egg fusion by 1,10-phenanthroline, using increasing
concentrations of chelator added after capacitation and the
acrosome reaction (see Fig. 1b for experimental design). As
shown in Fig. 2, inhibition of sperm–egg fusion was
concentration-dependent, with a virtually complete block
Class inhibited Inhibitor (concentration)a
All classes, not all proteases a2 Macroglobulin (1000 units)
spartic proteases Pepstatin (1.5 mM)
ysteine proteases E64 (30 mM)
erine proteases Pefabloc SC (1 mM)
etalloproteases AAF (3 mM)
1,10-Phenanthroline (1 mM)
a The maximum concentrations tested are given; these concentr
b IVF assays, 1/2 the inhibitor, were used to assess inhibitory act
;5 3 105 sperm/ml), then zona-free eggs were added to the sperm d
etermined. The total number of eggs tested for each proteas
macroglobulin, 50, 48 (means, n 5 3; P values for FR, FI, and No. s
17; Pefabloc SC, 15, 15. Note. Pepstatin, E64, and Pefabloc SC red
significant inhibition of the fertilization parameters, therefore the
c The following abbreviations are used: AAF, succ-Ala-Ala-Ph
fertilization; No. sperm/egg, number of sperm bound per egg.Copyright © 2000 by Academic Press. All rightt 500 mM and a complete block at 1 mM phenanthroline.
n contrast, there was no decrease (and perhaps a small
ncrease) in sperm–egg binding, which indicates that the
nhibited metalloprotease(s) functions after plasma mem-
rane binding (Fig. 2).
Additional experiments were done to determine if the
nhibitor must be present during sperm–egg interactions in
rder to block gamete fusion. When eggs or sperm were
ncubated with phenanthroline for the last 30 min of the
apacitation period, followed by washing (eggs) or dilution
nto fresh medium (sperm), sperm–egg fusion was not
IVFb,c controls IVF inhibitors
FI No. sperm/egg FR FI No. sperm/egg
1.5 8.3 87 1.6 10.3
1.1 2.0 87 1.1 5.6
1.1 2.0 82 1.1 3.4
1.3 5.5 87 0.9 18.5
See Table 2 Inhibits
See Figs. 2 and 3 Inhibits
s give strong inhibition in systems sensitive to the inhibitor.
. Inhibitors were added to capacitated and acrosome-reacted sperm
. After a 40-min incubation period, FR, FI, and No. sperm/egg were
ibitor and corresponding buffer control, respectively, were a2
/egg compared to controls were $0.75); pepstatin, 15, 17; E64, 16,
sperm viability during sperm and egg incubation, yet caused no
periments were not repeated.
C; FI, fertilization index; FR, fertilization rate; IVF, in vitro
TABLE 2
Effect of Synthetic Metalloprotease Peptide Substrate
on Sperm–Egg Fusion
Experimenta Peptide
Concentration
(mM) FRb FI
No. sperm/
egg
I None — 100 1.6 8.4
AAA 3 90.0 1.4 7.6
AAF 3 38.9 0.4 12.1
II AAA 2 93.3 1.0 5.6
AAF 2 6.3 0.1 9.3
a IVF assays were used to assess inhibitory activity. Inhibitors
ere added to capacitated and acrosome-reacted sperm, then zona-
ree eggs were added to the sperm drops. After a 40-min incubation
eriod, FR, FI, and No. sperm/egg were determined. The total
umber of eggs tested were Expt. I, 21 (no peptide), 20 (AAA), and
8 (AAF); Expt. II, 15 (AAA) and 16 (AAF).
b The following abbreviations are used: AAA, succ-Ala-Ala-Ala-
MC; AAF, succ-Ala-Ala-Phe-AMC; FI, fertilization index; FR,
ertilization rate; IVF, in vitro fertilization; No. sperm/egg, number
f sperm bound per egg.FR
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128 Correa et al.inhibited in either case (Figs. 1c and 1d). These findings
indicate that the metalloprotease activity is not irreversibly
inhibited by exposure to phenanthroline.
Characterization of the kinetics of sperm–egg fusion in
our assay shows that at 15 min of sperm–egg co-incubation
the fertilization rate is 30–50% of the final fertilization rate
obtained at 40 min of sperm–egg co-incubation (data not
shown). Thus at 15 min, at least half the fertilizable eggs
have not yet fused. When phenanthroline was added to
FIG. 2. The zinc chelator 1,10-phenanthroline blocks sperm–egg
fusion without decreasing binding. In IVF assays, 1,10-
phenanthroline was present throughout the 40-min insemination
period. The values shown are the means 6 SEM; n 5 3. The P
values for 0.35 and 0.5 mM 1,10-phenanthroline compared to no
inhibitor are ,0.003 and 0.0003 (FR) and , 0.01 and 0.002 (FI),
respectively. There was no statistically significant difference in the
mean number of sperm bound/egg compared to the control value.
The * indicates that there were no fused nuclei observed at 1.0 mM
1,10-phenanthroline. The total numbers of eggs tested in each
group were 69, 77, 77, and 72 (for 0, 0.35, 0.5, and 1.0 mM
1,10-phenanthroline, respectively).Copyright © 2000 by Academic Press. All rightusion obtained at 40 min (Fig. 1e). This suggests that the
etalloprotease acts during the initial 15-min co-
ncubation period of sperm and egg.
It is possible that a small hydrophobic compound such as
henanthroline may inhibit membrane fusion nonspecifi-
ally by intercalating into the plasma membrane and caus-
ng a change in the lipid organization. To test this possibil-
ty, a nonchelating structural isomer, 4,7-phenanthroline,
as tested in gamete fusion assays concurrently with the
inc chelator, 1,10-phenanthroline. As shown in Fig. 3,
,10-phenanthroline inhibited fusion in a dose-dependent
anner, while 4,7-phenanthroline had no effect on sperm–
gg fusion (P values for 4,7-phenanthroline relative to
ontrol for FR and FI: 0.427 and 0.313, respectively). In
ddition, 4,7-phenanthroline had no effect on gamete bind-
ng (data not shown). These findings suggest that the
bserved inhibition of fusion by 1,10-phenanthroline is due
o its ability to act as a chelator.
Metalloproteases require metal ions, usually zinc, for
atalytic activity. 1,10-Phenanthroline has a much higher
tability constant for Zn21 (2.5 3 106 M21) than for Ca21 (3.2
M21) and thus is a potent zinc chelator and a weak calcium
chelator. Consequently, 1,10-phenanthroline at 1 mM will
inhibit zinc metalloproteases in the presence of up to 10
mM calcium (discussed in Beynon and Bond, 1986). Cal-
cium in the range of 1.0–2.5 mM is optimal for mouse
sperm–egg fusion (Evans et al., 1995). The Ca21 concentra-
tion (1.8 mM) in our IVF medium should not be signifi-
cantly affected by 0.5–1.0 mM 1,10-phenanthroline which
is sufficient to block fusion. Therefore, 1,10-phenanthroline
presumably inhibits gamete fusion by removing zinc ions
required for activity of a putative Zn21-dependent metallo-
rotease.
FIG. 3. A nonchelating phenanthroline isomer does not inhibit
sperm–egg fusion. IVF assays, using both 4,7- and 1,10-
phenanthroline at the indicated concentrations, were carried out as
described for Figs. 1a and 1b. The mean FR is shown 6 SEM; n 5
6 for control (no addition) assays, n 5 2 for 0.5 mM and n 5 4 for
1 mM 4,7-phenanthroline. The P value for comparison of control
and 1 mM 4,7-phenanthroline assays 5 0.837.s of reproduction in any form reserved.
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Effects of Family-Specific Metalloprotease Inhibitors on Sperm–Egg Fusion
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129Metalloprotease in Sperm–Egg FusionAssignment of the Metalloprotease(s) Involved in
Sperm–Egg Fusion to a Specific Family of
Zn21-Metalloproteases
A variety of more specific inhibitors of Zn21-
etalloproteases was tested in fertilization assays in vitro,
n an effort to narrow down the identified activity to one or
few families. Zinc metalloproteases have been divided
nto several classes based on the sequences in and surround-
ng their zinc binding sites (Hooper, 1994). The names of
hese classes are gluzincins, metzincins, inverzincins, and
arboxypeptidases. Within each class, there are several
istinct families. Inhibitors are available for specific fami-
ies in the gluzincin class and metzincin class.
Inhibitors were tested at concentrations that yield strong
nhibition in other systems; the results of this set of
xperiments are summarized in Table 3. Actinonin, an
ntibiotic and hydroxamic acid derivative, has been re-
orted to be a strong inhibitor of the metalloexoproteases
minopeptidase M and leucine aminopeptidase (Umezawa
t al., 1985), members of the aminopeptidase family. Acti-
onin did not inhibit sperm–egg binding or plasma mem-
rane fusion. Phosphoramidon and captopril were first
escribed as potent inhibitors of the thermolysin family of
etalloproteases (Komiyama et al., 1975; Rasnick and
owers, 1978; Nishino and Powers, 1979). Phosphoramidon
s also a very potent inhibitor of mammalian
ndopeptidase-24.11, as well as other metalloproteases not
lassified in the thermolysin family (Bond and Butler, 1987;
oques and Beaumont, 1990; Hooper, 1994; Beynon and
Family inhibited Inhibitor (concentrat
Gluzincin class
Aminopeptidase, ACE Actinonin (20 mM)
ACE, Endopeptidase, and Thermolysin Captopril (100 mM)
Phosphoramidon (250
Metzincin class
MMP TIMP-1d (1.2 mM)
MMP, ADAM TIMP-3d (1.2 mM)
MMP, ADAM Ro 31-9790e ($25 mM
a The maximum concentrations tested are given; these concentr
b IVF assays were used to assess inhibitory activity. Inhibitors we
rops. After a 40-min incubation period, FR, FI, and No. sperm/egg
orresponding buffer control, respectively, were actinonin, 9, 8; cap
tested and none had an effect on fertilization), 83, 89. The * indi
experiments; however, no differences were observed in sperm bind
of the insemination drop.
c The following abbreviations are used: ACE, angiotensin con
adamalysin; FI, fertilization index; FR, fertilization rate; IVF, in vit
of sperm bound per egg; TIMP, tissue inhibitor of metalloprotease
d Generously provided by Dr. Gillian Murphy.
e Generously provided by Roche Discovery, Welwyn, England.Copyright © 2000 by Academic Press. All rightond, 1986). Captopril is a strong inhibitor of the mamma-
ian exoprotease angiotensin converting enzyme (ACE), of
he ACE family of metalloproteases (Roques and Beaumont,
990; Beynon and Bond, 1986). Since a testis-specific iso-
orm of ACE appears to be present on the sperm plasma
embrane (Langford et al., 1993; Sibony et al., 1994), ACE
inhibitors were important to test. It has been well docu-
mented that phosphoramidon and captopril do not inhibit
the matrixin (MMP) family (Bond and Butler, 1987; Gearing
et al., 1994; Beynon and Bond, 1986; Couet et al., 1996) and
at least one member of the adamalysin/reprolysin family of
metalloproteases (Mohler et al., 1994; Gearing et al., 1994).
Neither phosphoramidon nor captopril had an effect on
sperm–egg binding or fusion (Table 3).
Inhibitors specific for the MMP family were tested in
fusion assays to determine if this family may play a role in
sperm–egg fusion (Table 3). The MMPs are mammalian
proteases, such as the gelatinases, collagenases, stromel-
ysins, and matrilysin, that play important roles in degrada-
tion and remodeling of the extracellular matrix (Woessner,
1991; Matrisian, 1992; Sato et al., 1994; Brooks et al., 1996;
Couet et al., 1996; Holmbeck et al., 1999). The TIMPs
specifically inhibit MMPs and thus are an integral compo-
nent of the regulation of these metalloproteases in vivo
(Apte et al., 1995).
The hydroxamic acid derivative Ro 31-9790 (provided by
Roche Discovery Welwyn, England), a broad-spectrum
MMP inhibitor, significantly inhibited sperm–egg fusion.
As illustrated in Fig. 4, the presence of Ro 31-9790 in the
IVFb,c controls IVF inhibitors
FR FI No. sperm/egg FR FI No. sperm/egg
88 1.4 9.5 89 1.4 10.6
77 0.9 * 86 1.0 *
) 91 1.5 * 94 1.5 *
See Fig. 5 No inhibition
See Fig. 5 Inhibits
See Fig. 4 Inhibits
s give strong inhibition in systems sensitive to the inhibitor.
ded to capacitated sperm, then zona-free eggs were added to sperm
determined. The total number of eggs tested for each inhibitor and
l, 31, 31; phosphoramidon (concentrations from 50 to 250 mM were
that the number of sperm bound/egg was not counted for these
etween control and inhibitor groups by microscopic examination
ng enzyme; ADAM, a disintegrin and metalloprotease domain,
rtilization; MMP, matrix metalloprotease; No. sperm/egg, numberion)a
mM
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Two members of the TIMP family of proteins, TIMP-1
and TIMP-3, were also tested in IVF assays. TIMP-1, which
i
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130 Correa et al.insemination drop resulted in substantial, dose-dependent
inhibition of fusion. Incubation of gametes with all concen-
trations of Ro 31-9790 tested caused a significant decrease
in fertilization rate (for 25 to 200 mM, P values relative to
controls for FR were #0.0001; Fig. 4). The IC50 for Ro
31-9790 inhibition of sperm–egg fusion was ;20 mM. None
of the concentrations tested caused a reduction in the
number of sperm bound per egg (Fig. 4).
FIG. 4. The matrixin and adamalysin metalloprotease inhibitor
Ro 31-9790 inhibits sperm–egg fusion without decreasing sperm–
egg binding. IVF assays using increasing concentrations of Ro
31-9790 were used to assess inhibitory activity. The mean number
of sperm bound per egg, FR, and FI are shown, 6 SEM. For assays
with 0, 25, 50, 100, 200, and 500 mM Ro 31-9790, n 5 8, 4, 3, 4, 3,
nd 1, respectively. The P values for FR at all Ro 31-9790 concen-
rations compared to no inhibitor are #0.0001; P values for mean
number of sperm bound/egg at all concentrations are not signifi-
cant (ranging from 0.443 to 0.906). The total numbers of eggs tested
in each group were 145, 82, 64, 84, 63, and 14 (for 0, 25, 50, 100, 200,
and 500 mM Ro 31-9790, respectively).Copyright © 2000 by Academic Press. All rightnhibits essentially all MMPs except membrane type-1
MP (MT1-MMP; Will et al., 1996) and MMP-19, did not
inhibit sperm–egg binding or fusion (Fig. 5). However,
TIMP-3, an inhibitor of MMPs including MT1-MMP (Will
et al., 1996), and the adamalysin TACE (Amour et al., 1998),
did strongly inhibit sperm–egg fusion (Fig. 5). The IC50 for
nhibition of sperm–egg fusion by TIMP-3 was ;0.6 mM.
urthermore, TIMP-3 did not significantly affect the aver-
ge number of sperm bound per egg in these assays.
DISCUSSION
In the present study, we investigated whether metallo-
protease activity is important for fusion of gametes during
mammalian fertilization. Our results suggest that one or
more zinc metalloproteases must act after the sperm binds
to the egg plasma membrane in order for sperm and egg to
proceed to membrane fusion. We found that four distinct
kinds of metalloprotease inhibitors block sperm–egg fusion
without any effect on sperm–egg plasma membrane bind-
ing. The active inhibitors are the peptide substrate succ-
Ala-Ala-Phe-AMC, the zinc chelator 1,10-phenanthroline,
the hydroxamic acid derivative Ro 31-9790, and the endog-
enous MMP inhibitor TIMP-3. A substantial variety of
other inhibitors, which block other protease classes (aspar-
tic, cysteine, and serine proteases) or certain other families
of zinc metalloproteases, do not affect gamete fusion.
We found that the zinc chelator 1,10-phenanthroline, a
broad-spectrum inhibitor of zinc metalloproteases, can
completely block mouse sperm–egg fusion. The inhibitory
effect of 1,10-phenanthroline is reversible: if either gamete
is incubated with the chelator and then washed free of it,
gamete fusion is unaffected. Additionally, the inhibitor
must act within a short time window: if 1,10-
phenanthroline is added 15 min after sperm–egg co-
incubation begins, it has no effect on fusion. These findings
pinpoint a relatively brief time, the first 15 min of sperm
and egg co-incubation, in which the zinc metalloprotease
step(s) takes place.
Inhibitors of gluzincin families and of specific metzincin
families did not inhibit gamete fusion. However, the com-
pound Ro 31-9790, a hydroxamic acid derivative that is an
inhibitor of various metzincins in the matrixin and adama-
lysin families, did inhibit sperm–egg fusion. The IC50 of Ro
31-9790 for inhibition of gamete fusion is ;20 mM. This is
igher than the IC50 of Ro 31-9790 (2–3 mM) reported for
inhibition of the proteolytic release of L-selectin from the
cell surface, catalyzed by the adamalysin TACE (Preece et
al., 1996; Allport et al., 1997; Peschon et al., 1998). Simi-
larly, TIMP-3 protein strongly inhibited sperm–egg fusion,
while TIMP-1 protein had no effect on fusion in IVF assays.
In another study, TIMP-3 was found to inhibit the protease
activity of recombinant TACE, while TIMP-1 did not
(Amour et al., 1998). The IC50 for TIMP-3 inhibition ofs of reproduction in any form reserved.
The maximum level of inhibition by either TIMP-3 (at
the highest level tested, 1.2 mM) or Ro 31-9790 (at 100 mM)
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131Metalloprotease in Sperm–Egg Fusionfusion in our study was ;0.6 mM, similar to that reported for
TIMP-3 inhibition in other systems. For example, the IC50 for
TIMP-3 inhibition of shedding of L-selectin from leukocytes
was reported to be 0.3–0.4 mM (Borland et al., 1999).
FIG. 5. TIMP-3 but not TIMP-1 inhibits sperm–egg fusion and
oes not decrease sperm–egg binding. TIMP-1 (open circles and
pen bars) and TIMP-3 (closed circles and closed bars) were tested
n IVF assays as described. The FR, FI, and mean number of sperm
ound/egg are given 6 SEM. For TIMP-1 and corresponding control
ssays (no TIMP-1 added), n 5 3, and for TIMP-3 and corresponding
ontrol assays (no TIMP-3 added), n 5 4. There was no statistically
significant difference in FR and FI for TIMP-1 compared to the
appropriate control (no TIMP-1 added) nor for the mean number of
sperm bound per egg for TIMP-1 and TIMP-3 compared to corre-
sponding controls. The P values for FR and FI for TIMP-3 compared
to no inhibitor added are 0.004 and 0.02 at 0.6 mM TIMP-3 and
,0.0001 and 0.0006 at 1.2 mM TIMP-3, respectively. The total
umbers of eggs tested in assays using TIMP-1 were 66 and 71 (for
and 1.2 mM), and the total numbers of eggs tested in assays using
IMP-3 were 116, 70, and 107 (for 0, 0.6, and 1.2 mM, respectively).
D, not determined.Copyright © 2000 by Academic Press. All rightwas ;60%, while 1,10-phenanthroline was able to com-
pletely block sperm–egg fusion. Based on these findings, we
suggest that there may be two zinc metalloproteases in-
volved in sperm–egg fusion. One may be a member of the
matrixin or adamalysin family and highly sensitive to
TIMP-3 and Ro 31-9790 inhibition, while the second may
be from a different family, insensitive to these inhibitors
but sensitive to 1,10-phenanthroline. Alternatively, there
may be a single gamete metalloprotease related to but (in
terms of TIMP-3 and Ro 31-9790 sensitivity) different from
other members of the matrixin and adamalysin families.
The putative gamete metalloprotease might be structurally
different and have a rate of activity in the presence of
saturating TIMP-3 and Ro 31-9790 which is ;40% that of
the uninhibited enzyme.
The metalloprotease activity studied here is clearly dif-
ferent from that studied previously by Meizel and col-
leagues. They posited a role for a metalloprotease in an
earlier step in mammalian fertilization based on work using
human sperm and hamster eggs (Diaz-Perez et al., 1988;
Diaz-Perez and Meizel, 1992). In their studies, sperm were
incubated during the entire capacitation period with phos-
phoramidon (which has no effect on mouse gamete fusion
with our experimental design), a nonspecific metal ion
chelator (diethylenetriaminepentacetic acid), or a synthetic
metalloprotease substrate (carbobenoxy-L-phenylalanine).
perm were then washed and used in IVF assays. This
rotocol with these three inhibitors resulted in a 50–60%
ecrease in the average number of sperm that fused with
ggs (fertilization index). Meizel and co-workers concluded
hat a metalloprotease activity was important during the
crosome reaction and presumably metalloprotease inhibi-
ion during the acrosome reaction indirectly affected later
teps leading to sperm–egg fusion.
Our results with 1,10-phenanthroline and the synthetic
etalloprotease substrate are strikingly similar to those
ound in the study of sea urchin gamete fusion (Roe et al.,
988). Lennarz and colleagues found both the peptide succ-
la-Ala-Phe-AMC and 1,10-phenanthroline had no effect
n binding of acrosome-reacted sperm to the egg plasma
embrane but strongly blocked subsequent membrane
usion. More specific synthetic metalloprotease inhibitors
like Ro 31-9790) or natural inhibitor proteins such as the
IMPs were not available at the time of this previous study.
esults from the present study suggest the possibility that
here is a metalloprotease, or at least a similar proteolytic
rocess, that is conserved between invertebrate and mam-
alian gamete fusion.
Sensitivity to Ro 31-9790 and to TIMP-3 suggests that the
nhibited gamete metalloprotease could be related to the
atrixin or adamalysin families. Most metalloproteases of
he matrixin family are secreted enzymes, although the
ecently identified subset of membrane-type matrix metal-
oproteases (MT-MMPs) contains a transmembrane domain
Sato et al., 1994; Strongin et al., 1995; Will et al., 1996).s of reproduction in any form reserved.
The gamete metalloprotease identified in our study, pre-
sumably a membrane protein since the activity was inhib-
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